Better brain scan for small pituitary tumors in Cushing's disease
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a special type of brain scan (PET-MRI) to better find tiny pituitary tumors causing Cushing's disease. It may help people whose standard MRI didn't show a clear tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have Cushing's disease confirmed by blood or saliva tests (high ACTH and high cortisol).
- Your pituitary tumor is small (less than 1 cm) or was not clearly seen on a regular MRI.
- You do not have severe kidney or liver disease.
- You are not pregnant or breastfeeding, and have no history of allergic reactions to radioactive tracers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan using a tracer called FET to locate tiny ACTH-producing pituitary tumors (microadenomas) causing Cushing's disease. It might help guide surgery by identifying exactly where the tumor is in the gland.
This study uses a special PET scan (FET PET/CT) to help find tiny pituitary tumors causing Cushing disease. The goal is to improve surgery planning so the tumor can be removed successfully.
This Phase 2 trial tests fimepinostat (a targeted cancer-style drug) to help control Cushing disease caused by a pituitary tumor. It’s mainly for adults whose Cushing is confirmed to come from the pituitary and who meet safety and medication-washout rules.
This trial tests whether a special PET scan using a radioactive tracer called 18FET can better show hormone-producing pituitary tumors when the standard MRI is unclear. If the scan lights up the tumor, it could help guide surgery or radiation to treat it.
This study tests a new type of PET/MRI scan that uses a special tracer (18F-FET) to better find small pituitary tumors that didn't show up on a standard MRI. The goal is to help guide surgery to remove the tumor.
This study tests whether a combination of a drug called osilodrostat (which lowers cortisol levels) and a special PET scan can help find small pituitary tumors that MRI misses. This may help guide surgery or treatment for Cushing's disease.
Hear when a new Cushing Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.